These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

498 related items for PubMed ID: 15065019

  • 1. Phosphatidylinositol 3-kinase inhibition down-regulates survivin and facilitates TRAIL-mediated apoptosis in neuroblastomas.
    Kim S, Kang J, Qiao J, Thomas RP, Evers BM, Chung DH.
    J Pediatr Surg; 2004 Apr; 39(4):516-21. PubMed ID: 15065019
    [Abstract] [Full Text] [Related]

  • 2. Differential response of neuroblastoma cells to TRAIL is independent of PI3K/AKT.
    Efron PA, Chen MK, Iyengar M, Dai W, Nagaram A, Beierle EA.
    J Pediatr Surg; 2006 Jun; 41(6):1072-80. PubMed ID: 16769337
    [Abstract] [Full Text] [Related]

  • 3. Caspase-8 activation is necessary but not sufficient for tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-mediated apoptosis in the prostatic carcinoma cell line LNCaP.
    Rokhlin OW, Guseva NV, Tagiyev AF, Glover RA, Cohen MB.
    Prostate; 2002 Jun 01; 52(1):1-11. PubMed ID: 11992615
    [Abstract] [Full Text] [Related]

  • 4. Pro-survival function of Akt/protein kinase B in prostate cancer cells. Relationship with TRAIL resistance.
    Thakkar H, Chen X, Tyan F, Gim S, Robinson H, Lee C, Pandey SK, Nwokorie C, Onwudiwe N, Srivastava RK.
    J Biol Chem; 2001 Oct 19; 276(42):38361-9. PubMed ID: 11461904
    [Abstract] [Full Text] [Related]

  • 5. VEGF-mediated survivin expression in neuroblastoma cells.
    Beierle EA, Nagaram A, Dai W, Iyengar M, Chen MK.
    J Surg Res; 2005 Jul 01; 127(1):21-8. PubMed ID: 15882878
    [Abstract] [Full Text] [Related]

  • 6. Synergistic induction of apoptosis in neuroblastoma cells using a combination of cytostatic drugs with interferon-gamma and TRAIL.
    Johnsen JI, Pettersen I, Ponthan F, Sveinbjørnsson B, Flaegstad T, Kogner P.
    Int J Oncol; 2004 Dec 01; 25(6):1849-57. PubMed ID: 15547726
    [Abstract] [Full Text] [Related]

  • 7. Disruption of the inhibitor of apoptosis protein survivin sensitizes Bcr-abl-positive cells to STI571-induced apoptosis.
    Wang Z, Sampath J, Fukuda S, Pelus LM.
    Cancer Res; 2005 Sep 15; 65(18):8224-32. PubMed ID: 16166298
    [Abstract] [Full Text] [Related]

  • 8. Phosphatidylinositol 3-kinase/Akt positively regulates Fas (CD95)-mediated apoptosis in epidermal Cl41 cells.
    Lu B, Wang L, Stehlik C, Medan D, Huang C, Hu S, Chen F, Shi X, Rojanasakul Y.
    J Immunol; 2006 Jun 01; 176(11):6785-93. PubMed ID: 16709838
    [Abstract] [Full Text] [Related]

  • 9. Constitutively active Akt is an important regulator of TRAIL sensitivity in prostate cancer.
    Chen X, Thakkar H, Tyan F, Gim S, Robinson H, Lee C, Pandey SK, Nwokorie C, Onwudiwe N, Srivastava RK.
    Oncogene; 2001 Sep 20; 20(42):6073-83. PubMed ID: 11593415
    [Abstract] [Full Text] [Related]

  • 10. Targeted RNA interference of PI3K pathway components sensitizes colon cancer cells to TNF-related apoptosis-inducing ligand (TRAIL).
    Rychahou PG, Murillo CA, Evers BM.
    Surgery; 2005 Aug 20; 138(2):391-7. PubMed ID: 16153452
    [Abstract] [Full Text] [Related]

  • 11. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
    Mühlethaler-Mottet A, Flahaut M, Bourloud KB, Auderset K, Meier R, Joseph JM, Gross N.
    BMC Cancer; 2006 Aug 24; 6():214. PubMed ID: 16930472
    [Abstract] [Full Text] [Related]

  • 12. A new selective AKT pharmacological inhibitor reduces resistance to chemotherapeutic drugs, TRAIL, all-trans-retinoic acid, and ionizing radiation of human leukemia cells.
    Martelli AM, Tazzari PL, Tabellini G, Bortul R, Billi AM, Manzoli L, Ruggeri A, Conte R, Cocco L.
    Leukemia; 2003 Sep 24; 17(9):1794-805. PubMed ID: 12970779
    [Abstract] [Full Text] [Related]

  • 13. Prostate-apoptosis-response-gene-4 increases sensitivity to TRAIL-induced apoptosis.
    Boehrer S, Nowak D, Puccetti E, Ruthardt M, Sattler N, Trepohl B, Schneider B, Hoelzer D, Mitrou PS, Chow KU.
    Leuk Res; 2006 May 24; 30(5):597-605. PubMed ID: 16513168
    [Abstract] [Full Text] [Related]

  • 14. Interferon-gamma induces caspase-8 in neuroblastomas without affecting methylation of caspase-8 promoter.
    Kim S, Kang J, Evers BM, Chung DH.
    J Pediatr Surg; 2004 Apr 24; 39(4):509-15. PubMed ID: 15065018
    [Abstract] [Full Text] [Related]

  • 15. Regulation of survivin by PI3K/Akt/p70S6K1 pathway.
    Zhao P, Meng Q, Liu LZ, You YP, Liu N, Jiang BH.
    Biochem Biophys Res Commun; 2010 Apr 30; 395(2):219-24. PubMed ID: 20361940
    [Abstract] [Full Text] [Related]

  • 16. Agonists of an ecdysone-inducible mammalian expression system inhibit Fas Ligand- and TRAIL-induced apoptosis in the human colon carcinoma cell line RKO.
    Oehme I, Bösser S, Zörnig M.
    Cell Death Differ; 2006 Feb 30; 13(2):189-201. PubMed ID: 16082389
    [Abstract] [Full Text] [Related]

  • 17. Survivin inhibits apoptosis induced by TRAIL, and the ratio between survivin and TRAIL receptors is predictive of recurrent disease in neuroblastoma.
    Azuhata T, Scott D, Griffith TS, Miller M, Sandler AD.
    J Pediatr Surg; 2006 Aug 30; 41(8):1431-40. PubMed ID: 16863850
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of nuclear factor kappaB and phosphatidylinositol 3-kinase/Akt is essential for massive hepatocyte apoptosis induced by tumor necrosis factor alpha in mice.
    Imose M, Nagaki M, Naiki T, Osawa Y, Brenner DA, Asano T, Hayashi H, Kato T, Moriwaki H.
    Liver Int; 2003 Oct 30; 23(5):386-96. PubMed ID: 14708901
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.